Wang Ruiqiang, Wu Yunqi, Zhang Xiaofeng, An Dongyue, Guo Ningning, Guo Yuanyuan, Wang Jin, Tang Lin
Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Med (Lausanne). 2021 Sep 28;8:710386. doi: 10.3389/fmed.2021.710386. eCollection 2021.
The purpose of this study was to evaluate the clinicopathological features of different degrees of extraglomerular renal vascular lesions (RVLs) in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis and explore their clinical determinants. This is a retrospective study of 186 patients with ANCA-associated renal vasculitis diagnosed at the First Affiliated Hospital of Zhengzhou University from January 2014 to April 2019. The patients who met the inclusion criteria were divided into non-renal RVLs, mild RVLs, moderate RVLs, and severe RVLs. It was found that there were significant differences in serum creatinine (SCR), estimated glomerular filtration rate (eGFR), erythrocyte sedimentation rate (ESR), high-density lipoprotein (HDL), systolic blood pressure (SBP), the prevalence rate of hypertension, the proportion of normal glomeruli, and the proportion of sclerotic glomeruli and interstitial fibrosis integral. SCR and ESR are independent risk factors for RVLs. The participants were followed up for 1 year, and the progression to end-stage renal disease (ESRD) and death was defined as endpoint events. We found that the survival rate of patients without RVLs was significantly higher than that of patients with RVLs and that the RVLs were an independent risk factor for ESRD or death. Early intervention in the progression of RVLs can improve the prognosis.
本研究旨在评估抗中性粒细胞胞浆抗体(ANCA)相关性肾血管炎患者不同程度的肾外血管病变(RVL)的临床病理特征,并探讨其临床决定因素。这是一项对2014年1月至2019年4月在郑州大学第一附属医院诊断为ANCA相关性肾血管炎的186例患者的回顾性研究。符合纳入标准的患者分为无肾RVL、轻度RVL、中度RVL和重度RVL。结果发现,血清肌酐(SCR)、估计肾小球滤过率(eGFR)、红细胞沉降率(ESR)、高密度脂蛋白(HDL)、收缩压(SBP)、高血压患病率、正常肾小球比例、硬化肾小球比例和间质纤维化积分存在显著差异。SCR和ESR是RVL的独立危险因素。对参与者进行了1年的随访,将进展至终末期肾病(ESRD)和死亡定义为终点事件。我们发现,无RVL患者的生存率显著高于有RVL的患者,且RVL是ESRD或死亡的独立危险因素。对RVL进展进行早期干预可改善预后。